DiEtary Mimicry by Glucocorticoid Modulation Evaluation in ER+ Metastatic Breast Cancer Treatment: Efficacy and Response (DEMETER Trial)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a single centre, open label, phase II clinical study consisting of two parts, each consisting of a different dose of the same intervention to investigate the efficacy of dexamethasone as an adjunct to endocrine therapy in the treatment of ER+ HER2- metastatic breast cancer after progression on the same endocrine therapy.
Epistemonikos ID: f893fc31a78957a0b23460778427e2d6a42affcd
First added on: Aug 26, 2026